103
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

HIV Heterosexual Sexual Risk From Injecting Drug Users Among HIV-Seronegative Noninjecting Heroin Users

, , &
Pages 208-217 | Published online: 08 Feb 2011

REFERENCES

  • Allison, P. D. (1999). Logistic regression using the SAS system: Theory and application. Cary, NC: SAS Institute.
  • Anglin, M. D., Hser, Y., & McGlothin, X. (1987). Sex differences in addict careers. 2. Becoming addicted. American Journal of Drug and Alcohol Abuse, 13, 59–71.
  • Booth, R. E., Watters, J. K., & Chitwood, D. D. (1993). HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health, 83, 1144–1148.
  • Centers for Disease Control and Prevention. (2006). Methamphetamine use and HIV risk behaviors among heterosexual men—Preliminary results from five northern California counties, December 2001–November 2003. MMWR Morbidity and Mortality Weekly Report, 55, 273–277.
  • Chiasson, M. A., Stoneburner, R. L., Hildebrandt, D. S., Ewing, W. E., Telzak, E. E., & Jaffe, H. W. (1991). Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS, 5, 1121–1126.
  • Crofts, N., Louie, R., Rosenthal, D., & Jolly, D. (1996). The first hit: Circumstances surrounding initiation into injecting. Addiction, 91, 1187–1196.
  • de la Fuente, L., Saavedra, P., Barrio, G., Royuela, L., Vincente, J., & Spanish Group for the Study of the Purity of Seized Drugs. (1996). Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Drug and Alcohol Dependence, 40, 185–194.
  • Des Jarlais, D. C., Arasteh, K., Perlis, T., Hagan, H., Abdul-Quader, A., Heckathorn, D. D., (2007). Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS, 21, 231–235.
  • Diaz, T., Vlahov, D., Edwards, V., Conover, S., & Monterroso, E. (2002). Sex specific differences in circumstances of initiation into injection-drug use among young adult Latinos in Harlem, New York City. AIDS and Behavior, 6, 117–122.
  • Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., (1994). Intersecting epidemics—Crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. The New England Journal of Medicine, 331, 1422–1427.
  • Evans, J. L., Hahn, J. A., Page-Shafer, K., Lum, P. J., Stein, E. S., Davidson, P. J., (2003). Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of Urban Health, 80, 137–146.
  • Fleming, D. T., & Wasserheit, J. N. (1999). From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections, 75, 3–17.
  • Frajzyngier, V., Neaigus, A., Gyarmathy, V. A., Miller, M., & Friedman, S. R. (2007). Gender differences in injection risk behaviors at the first injection episode. Drug and Alcohol Dependence, 89(2-3), 145–152.
  • Friedman, S. R., Kippax, S. C., Phaswana-Mafuya, N., Rossi, D., & Newman, C. E. (2006). Emerging future issues in HIV/AIDS social research [Review]. AIDS, 20(7), 959–965.
  • Frosch, D., Shoptaw, S., Huber, A., Rawson, R. A., & Ling, W. (1996). Sexual HIV risk among gay and bisexual male methamphetamine abusers. Journal of Substance Abuse Treatment, 13, 483–486.
  • Fullilove, R. E., Fullilove, M. T., Bowser, B., & Gross, S. (1990a). Crack users: The new AIDS risk group? Cancer Detection Prevention, 14, 363–368.
  • Fullilove, R. E., Fullilove, M. T., Bowser, B. P., & Gross, S. A. (1990b). Risk of sexually transmitted disease among black adolescent crack users in Oakland and San Francisco, Calif. The Journal Of the American Medical Association, 263, 851–855.
  • Gibson, D. R., Leamon, M. H., & Flynn, N. (2002). Epidemiology and public health consequences of methamphetamine use in California's Central Valley. Journal of Psychoactive Drugs, 34, 313–319.
  • Grund, J. P., & Blanken, P. (1993). From chasing the dragon to chinezen: The diffusion of heroin smoking in the Netherlands. Rotterdam, The Netherlands: Institut Voor Verslavinason der Zoek, Erazmus University.
  • Gyarmathy, V. A., Neaigus, A., Miller, M., Friedman, S. R., Des Jarlais, D. C. (2002). Risk correlates of prevalent HIV, Hepatitis B Virus, and Hepatitis C Virus infections among noninjecting heroin users. Journal of Acquired Immune Deficiency Syndromes, 30, 448–56.
  • Halkitis, P. N., Green, K. A., & Mourgues, P. (2005). Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: Findings from Project BUMPS. Journal of Urban Health, 82, i18–i25.
  • Hser, Y. I., Chou, C. P., Hoffman, V., & Anglin, M. D. (1999). Cocaine use and high-risk sexual behavior among STD clinic patients. Sexually Transmitted Diseases, 26, 82–86.
  • Kral, A. H., Bluthenthal, R. N., Booth, R. E., & Watters, J. K. (1998). HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. American Journal of Public Health, 88, 108–113.
  • Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet, 357, 1397–1401.
  • Logan, T. K., & Leukefeld, C. (2000). Sexual and drug use behaviors among female crack users: A multi-site sample. Drug and Alcohol Dependence, 58, 237–245.
  • Marel, R., Galea, J., & Smith, R. B. (2005 January). Drug use trends in New York city. Paper presented at Epidemiologic Trends in Drug Abuse II, Proceedings of the Community Epidemiology Work Group. National Institute on Drug Abuse, Bethesda, MD.
  • Miller, M., & Neaigus, A. (2001). Networks, resources and risk among women who use drugs. Social Science and Medicine, 52, 967–978.
  • Miller, M., & Neaigus, A. (2002). Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care, 14, 801–813.
  • Miller, M., & Paone, D. (1998). Social network characteristics as mediators in the relationship between sexual abuse and HIV risk. Social Science and Medicine, 47, 765–777.
  • Neaigus, A., Friedman, S. R., Goldstein, M. F., Ildefonso, G., Curtis, R., & Jose, B. (1995). Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Research Monograph, 151, 20–37.
  • Neaigus, A., Miller, M., Friedman, S. R., & Des Jarlais, D. C. (2001). Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. Journal of Infectious Diseases, 184, 359–363.
  • Neaigus, A., Miller, M., Friedman, S. R., Hagen, D. L., Sifaneck, S. J., Ildefonso, G., (2001). Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction, 96(6) 839–852.
  • Neaigus, A., Gyarmathy, V. A., Miller, M., Frajzyngier, V. M., Friedman, S. R., & Des Jarlais, D. C. (2006). Transitions to injecting drug use among non-injecting heroin users: Social network influence and individual susceptibility. Journal of Acquired Immune Deficiency Syndromes, 41, 493–503.
  • Neaigus, A., Gyarmathy, V. A., Miller, M., Frajzyngier, V., Zhao, M., Friedman, S. R., (2007). Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug and Alcohol Dependence, 89(2-3), 234–243.
  • Neaigus, A., Zhao, M., Gyarmathy, V. A., Cisek, L., Friedman, S. R., & Baxter, R. C. (2008). Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. Journal Urban Health, 85, 309–322.
  • Ross, M. W., Hwang, L. Y., Zack, C., Bull, L., & Williams, M. L. (2002). Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. International Journal of STD & AIDS, 13, 769–774.
  • Sanchez, J., Comerford, M., Chitwood, D. D., Fernandez, M. I., & McCoy, C. B. (2002). High risk sexual behaviours among heroin sniffers who have no history of injection drug use: Implications for HIV risk reduction. AIDS Care, 14, 391–398.
  • Schottenfeld, R. S., O'Malley, S., Abdul-Salaam, K., & O'Connor, P. G. (1993). Decline in intravenous drug use among treatment-seeking opiate users. Journal of Substance Abuse Treatment, 10, 5–10.
  • Sifaneck, S. J., & Neaigus A. (2001). The ethnographic accessing, sampling and screening of hidden populations: Heroin sniffers in New York City. Addiction Research & Theory, 9(6), 519–543.
  • Strang, J., Griffiths, P., Powis, B., & Gossop, M. (1992). First use of heroin: Changes in the route of administration over time. British Medical Journal, 304, 1222–1223.
  • Strathdee, S. A., & Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80, 7–14.
  • Substance Abuse and Mental Health Services Administration. (2005). Results from the 2004 National Survey on Drug Use and Health: National Findings. Report No. SMA 05–4062. Rockville, MD: Department of Health and Human Services.
  • Tortu, S., Beardsley, M., Deren, S., Williams, M., McCoy, H. V., Stark, (2000). HIV infection and patterns of risk among women drug injectors and crack users in low and high sero-prevalence sites. AIDS Care, 12, 65–76.
  • United Nations Office on Drugs and Crime. (2005). World Drug Report 2005: Volume 1 Analysis. Report No. UNIS/NAR/. Vienna, Austria: United Nations Information Service.
  • Wasserheit, J. N. (1992). Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sexually Transmitted Diseases, 19, 61–77.
  • Woody, G. E., Donnell, D., Seage, G. R., Metzger, D., Marmor, M., Koblin, B. A., (1999). Non-injection substance use correlates with risky sex among men having sex with men: Data from HIVNET. Drug and Alcohol Dependence, 53, 197–205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.